AIP
ASMB icon

Ameritas Investment Partners’s Assembly Biosciences ASMB Stock Holding History

Ameritas Investment Partners’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-206
Closed -$11K – 3056
2021
Q1 		$11K Hold
206
– – ﹤0.01% 2799
2020
Q4 		$15K Hold
206
– – ﹤0.01% 2603
2020
Q3 		$41K Hold
206
– – ﹤0.01% 1949
2020
Q2 		$58K Buy
206
+34
+20% +$7.93K ﹤0.01% 1740
2020
Q1 		$31K Buy
172
+31
+22% +$6.64K ﹤0.01% 1922
2019
Q4 		$35K Hold
141
– – ﹤0.01% 2108
2019
Q3 		$17K Hold
141
– – ﹤0.01% 2465
2019
Q2 		$23K Hold
141
– – ﹤0.01% 2361
2019
Q1 		$33K Hold
141
– – ﹤0.01% 2099
2018
Q4 		$38K Hold
141
– – ﹤0.01% 1964
2018
Q3 		$63K Buy
141
+26
+23% +$12.2K ﹤0.01% 1855
2018
Q2 		$54K Hold
115
– – ﹤0.01% 1941
2018
Q1 		$68K Buy
115
+12
+12% +$7.44K ﹤0.01% 1734
2017
Q4 		$56K Hold
103
– – ﹤0.01% 1865
2017
Q3 		$33K Hold
103
– – ﹤0.01% 2125
2017
Q2 		$25K Buy
+103
New +$29K ﹤0.01% 2327

Other funds holding ASMB

AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Ameritas Investment Partners's ASMB Position: Q2 2021 in Review

Ameritas Investment Partners sold out of Assembly Biosciences (ASMB) in Q2 2021, closing a stake of 206 shares — an estimated $11K sold.

Ameritas Investment Partners first reported a position in ASMB in Q2 2017 and held it in 16 quarters. The position peaked at $68K in Q1 2018. 91 funds tracked by Wall St. Rank hold ASMB as of Q2 2021.

  • Ameritas Investment Partners reported no remaining Assembly Biosciences position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Partners sold 206 Assembly Biosciences shares in Q2 2021, an estimated $11K.
  • Ameritas Investment Partners first reported a position in Assembly Biosciences in Q2 2017 and held it in 16 quarters.
  • Ameritas Investment Partners's Assembly Biosciences position peaked at $68K in Q1 2018.
  • 91 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2021.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.